In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Elizabeth Karvonen, The Emerson Group
Future of Commerce event set for July in Boston.
Video Forum: Chip Davis, Healthcare Distribution Alliance
Strengthening the Pharmaceutical Supply Chain.
Latest
MarketCast ranks the 50 brands Americans can't live without
“The strongest brands today aren't just seen or heard; they're felt,” said Ed Trujillo, SVP of Brand Solutions at MarketCast.
Mars goes Mesozoic: M&M'S releases Jurassic World Rebirth packs
The collaboration features three collectible M&M’S Mega Peanut Butter packs, showcasing designs inspired by the film’s dino-fueled action.
Walgreens and KFF’s Greater Than campaign to offer free HIV/STD testing in stores on June 27
More than 415 local health departments and community organizations mobilize across the country for largest-ever National HIV Testing Day event.
Amneal gets FDA approval for prednisolone acetate ophthalmic suspension
Prednisolone acetate ophthalmic suspension, USP 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is indicated for treating steroid-responsive ocular inflammation.